Harbor Capital Advisors, Inc. Precision Biosciences Inc Transaction History

Harbor Capital Advisors, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 08, 2024	BUY	$0.29 - $0.45 $4,972 - $7,715	17,145 Added 12.93%	149,733 $53,000
Q3 2023 Oct 20, 2023	BUY	$0.34 - $0.69 $7,214 - $14,641	21,220 Added 19.05%	132,588 $45,000
Q2 2023 Jul 11, 2023	BUY	$0.52 - $0.91 $5,308 - $9,290	10,209 Added 10.09%	111,368 $59,000
Q1 2023 Apr 26, 2023	SELL	$0.7 - $1.41 $6,181 - $12,450	-8,830 Reduced 8.03%	101,159 $75,000
Q4 2022 Jan 20, 2023	SELL	$0.97 - $45.0 $2,285 - $106,020	-2,356 Reduced 2.1%	109,989 $0
Q3 2022 Oct 28, 2022	BUY	$1.22 - $40.8 $22,327 - $746,680	18,301 Added 19.46%	112,345 $1.47 Million
Q2 2022 Jul 26, 2022	SELL	$1.15 - $3.34 $6,581 - $19,114	-5,723 Reduced 5.74%	94,044 $150,000
Q1 2022 Apr 28, 2022	SELL	$2.96 - $7.76 $62,269 - $163,247	-21,037 Reduced 17.41%	99,767 $307,000
Q4 2021 Feb 04, 2022	BUY	$7.4 - $11.66 $893,949 - $1.41 Million	120,804 New	120,804 $894,000

2.56M

Ticker DTIL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 110,818,000
Market Cap $584M
Description
Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing and ex vivo allogeneic CAR T therapies in the United States. It offers ARCUS, a genome editing platform to cure genetic disorders. The company also provides Ex vivo Allogeneic CAR T Immunotherapy, a form of immunotherapy in which T cell, a specific ...

Get notified when there are updates to the investment portfolio of Harbor Capital Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Harbor Capital Advisors, Inc. with notifications on news.